Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Arthropod-borne encephalitides

Lyle R Petersen, MD, MPH
Section Editor
Martin S Hirsch, MD
Deputy Editor
Jennifer Mitty, MD, MPH


Arthropod-borne encephalitis viruses represent a significant public health problem throughout most of the world. These viruses, which belong to the families Flaviviridae, Togaviridae, Bunyaviridae, and Reoviridae, are usually highly adapted to particular reservoir hosts and are spread from animal to animal via the bite of an infected arthropod, usually a specific mosquito or tick species (table 1).

This topic will review the major characteristics of most of the arthropod-borne viral encephalitides. General issues related to viral encephalitis, including clinical manifestations, cerebrospinal fluid findings, distinction from postinfectious encephalitis and meningitis, and an approach to the patients with suspected central nervous system infection are discussed separately. (See "Viral encephalitis in adults".)


The mosquito or tick becomes infected when feeding on the blood of the viremic animal. The virus then replicates in the mosquito or tick tissues, ultimately infecting the salivary glands. The mosquito or tick transmits the virus to a new host when it injects infective salivary fluid while taking a blood meal.

The natural animal hosts of these viruses usually remain unaffected and viral circulation generally remains undetected until one of the following occurs:

Humans encroach on the natural enzootic focus

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Aug 14, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Johnson BW, Kosoy O, Martin DA, et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis 2005; 5:137.
  2. Arrigo NC, Adams AP, Weaver SC. Evolutionary patterns of eastern equine encephalitis virus in North versus South America suggest ecological differences and taxonomic revision. J Virol 2010; 84:1014.
  3. Centers for Disease Control and Prevention (CDC). Eastern Equitne Encephalitis; epidemiology and geographic distribution. https://www.cdc.gov/easternequineencephalitis/tech/epi.html (Accessed on August 14, 2017).
  4. Centers for Disease Control and Prevention (CDC). Eastern equine encephalitis--New Hampshire and Massachusetts, August-September 2005. MMWR Morb Mortal Wkly Rep 2006; 55:697.
  5. Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997; 336:1867.
  6. Silverman MA, Misasi J, Smole S, et al. Eastern equine encephalitis in children, Massachusetts and New Hampshire,USA, 1970-2010. Emerg Infect Dis 2013; 19:194.
  7. Centers for Disease Control and Prevention. National notifiable diseases surveillance system (NNDSS). Arboviral Diseases, Neuroinvasive and Non-neuroinvasive 2015 Case Definition. https://wwwn.cdc.gov/nndss/conditions/arboviral-diseases-neuroinvasive-and-non-neuroinvasive/case-definition/2015/ (Accessed on August 09, 2017).
  8. Golomb MR, Durand ML, Schaefer PW, et al. A case of immunotherapy-responsive eastern equine encephalitis with diffusion-weighted imaging. Neurology 2001; 56:420.
  9. Wendell LC, Potter NS, Roth JL, et al. Successful management of severe neuroinvasive eastern equine encephalitis. Neurocrit Care 2013; 19:111.
  10. Mukerji SS, Lam AD, Wilson MR. Eastern Equine Encephalitis Treated With Intravenous Immunoglobulins. Neurohospitalist 2016; 6:29.
  11. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994; 7:89.
  12. Erwin PC, Jones TF, Gerhardt RR, et al. La Crosse encephalitis in Eastern Tennessee: clinical, environmental, and entomological characteristics from a blinded cohort study. Am J Epidemiol 2002; 155:1060.
  13. Centers for Disease Control and Prevention (CDC). Arboviral infections of the central nervous system--United States, 1996-1997. MMWR Morb Mortal Wkly Rep 1998; 47:517.
  14. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001; 344:801.
  15. McJunkin JE, Khan R, de los Reyes EC, et al. Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics 1997; 99:261.
  16. Centers for Disease Control and Prevention (CDC). Possible congenital infection with La Crosse encephalitis virus--West Virginia, 2006-2007. MMWR Morb Mortal Wkly Rep 2009; 58:4.
  17. Mackenzie JS, Lindsay MD, Coelen RJ, et al. Arboviruses causing human disease in the Australasian zoogeographic region. Arch Virol 1994; 136:447.
  18. Burrow JN, Whelan PI, Kilburn CJ, et al. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987-1996. Aust N Z J Med 1998; 28:590.
  19. Kienzle N, Boyes L. Murray Valley encephalitis: case report and review of neuroradiological features. Australas Radiol 2003; 47:61.
  20. Forrester NL, Wertheim JO, Dugan VG, et al. Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas. PLoS Negl Trop Dis 2017; 11:e0005693.
  21. Kaiser R. Tick-borne encephalitis. Infect Dis Clin North Am 2008; 22:561.
  22. Süss J. Epidemiology and ecology of TBE relevant to the production of effective vaccines. Vaccine 2003; 21 Suppl 1:S19.
  23. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet 2008; 371:1861.
  24. Lipowski D, Popiel M, Perlejewski K, et al. A Cluster of Fatal Tick-borne Encephalitis Virus Infection in Organ Transplant Setting. J Infect Dis 2017; 215:896.
  25. Kaiser R, Holzmann H. Laboratory findings in tick-borne encephalitis--correlation with clinical outcome. Infection 2000; 28:78.
  26. Kindberg E, Mickiene A, Ax C, et al. A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 2008; 197:266.
  27. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 2003; 21 Suppl 1:S36.
  28. Haglund M, Günther G. Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up. Vaccine 2003; 21 Suppl 1:S11.
  29. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients. Brain 1999; 122 ( Pt 11):2067.
  30. Barrett PN, Schober-Bendixen S, Ehrlich HJ. History of TBE vaccines. Vaccine 2003; 21 Suppl 1:S41.
  31. Heinz FX, Stiasny K, Holzmann H, et al. Vaccination and tick-borne encephalitis, central Europe. Emerg Infect Dis 2013; 19:69.
  32. Centers for Disease Control and Prevention (CDC). Tick-borne encephalitis among U.S. travelers to Europe and Asia - 2000-2009. MMWR Morb Mortal Wkly Rep 2010; 59:335.
  33. Ebel GD. Update on Powassan virus: emergence of a North American tick-borne flavivirus. Annu Rev Entomol 2010; 55:95.
  34. Gholam BI, Puksa S, Provias JP. Powassan encephalitis: a case report with neuropathology and literature review. CMAJ 1999; 161:1419.
  35. Centers for Disease Control and Prevention (CDC). Outbreak of Powassan encephalitis--Maine and Vermont, 1999-2001. MMWR Morb Mortal Wkly Rep 2001; 50:761.
  36. Centers for Disease Control and Prevenion. Powassan virus. Statistics and maps. https://www.cdc.gov/powassan/statistics.html (Accessed on August 09, 2017).
  37. Lessell S, Collins TE. Ophthalmoplegia in Powassan encephalitis. Neurology 2003; 60:1726.
  38. Hinten SR, Beckett GA, Gensheimer KF, et al. Increased recognition of Powassan encephalitis in the United States, 1999-2005. Vector Borne Zoonotic Dis 2008; 8:733.
  39. Yendell SJ, Fischer M, Staples JE. Colorado tick fever in the United States, 2002-2012. Vector Borne Zoonotic Dis 2015; 15:311.
  40. Transmission of Colorado tick fever virus by blood transfusion--Montana. MMWR Morb Mortal Wkly Rep 1975; 24:422.
  41. Goodpasture HC, Poland JD, Francy DB, et al. Colorado tick fever: clinical, epidemiologic, and laboratory aspects of 228 cases in Colorado in 1973-1974. Ann Intern Med 1978; 88:303.
  42. Spruance SL, Bailey A. Colorado Tick Fever. A review of 115 laboratory confirmed cases. Arch Intern Med 1973; 131:288.
  43. Johnson AJ, Karabatsos N, Lanciotti RS. Detection of Colorado tick fever virus by using reverse transcriptase PCR and application of the technique in laboratory diagnosis. J Clin Microbiol 1997; 35:1203.
  44. Rao BL, Basu A, Wairagkar NS, et al. A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus. Lancet 2004; 364:869.
  45. Jacob John T. Chandipura virus - what we know & do not know. Indian J Med Res 2010; 132:125.
  46. Chadha MS, Arankalle VA, Jadi RS, et al. An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India. Am J Trop Med Hyg 2005; 73:566.
  47. Gurav YK, Tandale BV, Jadi RS, et al. Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. Indian J Med Res 2010; 132:395.
  48. Charrel RN, Gallian P, Navarro-Mari JM, et al. Emergence of Toscana virus in Europe. Emerg Infect Dis 2005; 11:1657.
  49. Di Nicuolo G, Pagliano P, Battisti S, et al. Toscana virus central nervous system infections in southern Italy. J Clin Microbiol 2005; 43:6186.